Detailed answers about GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD, including incorporation, status, business activity, and accounts information.
When was GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD founded?
GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD was officially incorporated on 4 July 2020 and is registered under company number 12718625. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD?
GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD do?
GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD's registered address?
The registered office address of GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD is 53 WHATELEYS DRIVE, KENILWORTH, WARWICKSHIRE, CV8 2GY. This is the official address filed with Companies House for legal and statutory correspondence.
Is GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD financially stable?
The most recent accounts for GERMANY KEBEN BIO TECHNOLOGY (INTERNATIONAL) LTD were made up to 31 July 2025, filed as DORMANT. Next accounts are due by 30 April 2027.